| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/2004 | CA2185983C Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| 04/13/2004 | CA2182397C Endotoxin reduction or removal process |
| 04/13/2004 | CA2147123C Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/13/2004 | CA2090953C High pullulan content product, and its preparation and uses |
| 04/11/2004 | CA2407755A1 Inhibition of vegf secretion |
| 04/10/2004 | CA2445212A1 Treatment of sexual dysfunction |
| 04/08/2004 | WO2004029291A1 Method of evaluationg canceration degree of mammal-origin specimen |
| 04/08/2004 | WO2004029281A2 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 04/08/2004 | WO2004029208A2 Cell separation compositions and methods |
| 04/08/2004 | WO2004029204A2 Substituted pyrimidines |
| 04/08/2004 | WO2004029137A2 Cross-linked polymer matrices, and methods of making and using same |
| 04/08/2004 | WO2004029104A1 Phospholipid derivative |
| 04/08/2004 | WO2004029068A1 Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease |
| 04/08/2004 | WO2004029059A1 N-substituted hydromorphones and the use thereof |
| 04/08/2004 | WO2004029058A1 Medicinal composition for inhibiting increase in blood gastrin concentration |
| 04/08/2004 | WO2004029057A1 Medicinal composition for treatment for or prevention of visceral pain |
| 04/08/2004 | WO2004029054A1 Novel adenine compound and use thereof |
| 04/08/2004 | WO2004029051A1 Pyrazole amides for treating hiv infections |
| 04/08/2004 | WO2004029049A1 Novel salt of 2-acylaminothiazole derivative |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004029036A1 Novel method for the industrial synthesis of strontium ranelate and the hydrates thereof |
| 04/08/2004 | WO2004029025A2 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 04/08/2004 | WO2004028677A2 Perfluorocarbon emulsions with non-fluorinated surfactants |
| 04/08/2004 | WO2004028634A1 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 04/08/2004 | WO2004028589A2 Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
| 04/08/2004 | WO2004028578A1 Composition for stimulating bone-formation and bone consolidation |
| 04/08/2004 | WO2004028570A2 A method for treating severe tinnitus |
| 04/08/2004 | WO2004028558A1 Preventives/remedies for neurodegenerative disease |
| 04/08/2004 | WO2004028549A1 A coixenolide capsules for treating prostate disease |
| 04/08/2004 | WO2004028548A2 Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents |
| 04/08/2004 | WO2004028546A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | WO2004028545A1 A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
| 04/08/2004 | WO2004028544A1 Use of mas-compounds for treating diseases associated with lipid metabolism |
| 04/08/2004 | WO2004028543A1 Progesterone receptor antagonists for reducing incidence of stillborn pigs |
| 04/08/2004 | WO2004028542A1 Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes |
| 04/08/2004 | WO2004028541A2 Composition for the treatment of nasopharyngeal carcinoma and use thereof |
| 04/08/2004 | WO2004028540A1 Anti-neurodegenerative agents |
| 04/08/2004 | WO2004028538A1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 04/08/2004 | WO2004028537A1 Use of thiazolidinedione derivatives as aldose reductase inhibitors |
| 04/08/2004 | WO2004028536A1 Method for topical treatment of eye disease and composition and device for said treatment |
| 04/08/2004 | WO2004028535A1 Pin1-modulating compounds and methods of use thereof |
| 04/08/2004 | WO2004028534A1 Controlled releases system containing temozolomide |
| 04/08/2004 | WO2004028533A1 Method of treating sleeplessness with melatonin on an acute basis |
| 04/08/2004 | WO2004028532A1 Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder |
| 04/08/2004 | WO2004028531A1 Preventive or remedy for bedsore |
| 04/08/2004 | WO2004028530A1 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | WO2004028528A1 Amino acid compositions for improving central functions |
| 04/08/2004 | WO2004028527A1 Synergistic combinations of dietary fiber and n-saids for the treatment of cancer |
| 04/08/2004 | WO2004028526A1 Therapeutic agent for rheumatism containing benzamide derivative as active ingredient |
| 04/08/2004 | WO2004028525A1 Choline ascorbate formulations |
| 04/08/2004 | WO2004028524A1 Combination drug |
| 04/08/2004 | WO2004028523A1 Particulate product comprising pantethine |
| 04/08/2004 | WO2004028522A1 Analgesic compositions comprising nmda receptor antagonists and benzalkonium chloride |
| 04/08/2004 | WO2004028521A2 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 04/08/2004 | WO2004028520A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 04/08/2004 | WO2004028519A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 04/08/2004 | WO2004028518A1 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 04/08/2004 | WO2004028517A1 A method for treating severe tinnitus |
| 04/08/2004 | WO2004028516A2 Compositions for the inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases |
| 04/08/2004 | WO2004028509A1 Sustained released delivery of amphetamine salts |
| 04/08/2004 | WO2004028507A1 Method to improve pharmaceutical tablets having a matrix of cellulose ether |
| 04/08/2004 | WO2004028506A1 Oral pharmaceutical compositions of fenofibrate having high bioavailability |
| 04/08/2004 | WO2004028505A1 Solid pharmaceutical formulations comprising telmisartan |
| 04/08/2004 | WO2004028502A1 Cleansing composition containing antifungal agent and antibacterial agent |
| 04/08/2004 | WO2004028495A1 Hair treatment agent containing an active combination of liposomes |
| 04/08/2004 | WO2004028484A1 Demelanizing agents, beautifying agents, demelanizing compositions and beautifying compositions |
| 04/08/2004 | WO2004028481A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/08/2004 | WO2004028480A2 Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 04/08/2004 | WO2004028477A2 Methods for treatment and/or prevention of retinal disease |
| 04/08/2004 | WO2004028476A2 Artemisinin-derived trioxane dimers |
| 04/08/2004 | WO2004028474A2 Caspase inhibitors as anticancer agents |
| 04/08/2004 | WO2004028470A2 Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation |
| 04/08/2004 | WO2004028469A2 Docohexaenoic acid for improved glycemic control |
| 04/08/2004 | WO2004028468A2 Methods and compositions for treatment of neurological disorder |
| 04/08/2004 | WO2004028465A2 Hemostatic compositions and methods |
| 04/08/2004 | WO2004028463A2 Methods and compositions for the treatment of lupus using clofarabine |
| 04/08/2004 | WO2004028461A2 Antiseptic solutions containing silver chelated with polypectate and edta |
| 04/08/2004 | WO2004028459A2 Piperidine derivatives |
| 04/08/2004 | WO2004028455A2 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 04/08/2004 | WO2004028454A2 1, 3, 5-triazines for treatment of viral diseases |
| 04/08/2004 | WO2004028453A2 Methods for preventing and treating obesity in patients with mc4 receptor mutations |
| 04/08/2004 | WO2004028451A2 β-HYDROXYPHENYLALKYLAMINES AND THEIR USE FOR TREATING GLAUCOMA |
| 04/08/2004 | WO2004028448A2 Method of alleviating pain via inhibition of neurotransmitter synthesis |
| 04/08/2004 | WO2004028446A2 Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease |
| 04/08/2004 | WO2004028444A2 Parathyroid hormone antagonists and uses thereof |
| 04/08/2004 | WO2004028443A2 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 04/08/2004 | WO2004028442A2 Use of excipients to increase dna uptake by swine muscle cells |
| 04/08/2004 | WO2004028441A2 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 04/08/2004 | WO2004028440A2 Vr1 antagonists for the treatment of urological disorders |
| 04/08/2004 | WO2004028272A2 Injectable growth promoting and anthelmintic composition |
| 04/08/2004 | WO2004022629A3 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid |
| 04/08/2004 | WO2004022573A3 Adenosine a3 receptor agonists |
| 04/08/2004 | WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/08/2004 | WO2004016635A3 Partial and full agonists of a1 adenosine receptors |
| 04/08/2004 | WO2004016580A3 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 04/08/2004 | WO2004016242A3 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles |
| 04/08/2004 | WO2004015096A3 Leech extracts for stents |
| 04/08/2004 | WO2004014893A3 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 04/08/2004 | WO2004014396A9 Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin |